Published in Stem Cells Int on April 27, 2015
Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets. Stem Cells Int (2016) 0.85
Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites. Front Oncol (2015) 0.79
Estrogen Exhibits a Biphasic Effect on Prostate Tumor Growth through the Estrogen Receptor β-KLF5 Pathway. Mol Cell Biol (2015) 0.75
Immune Regulation by Pericytes: Modulating Innate and Adaptive Immunity. Front Immunol (2016) 0.75
Paracrine influence of human perivascular cells on the proliferation of adenocarcinoma alveolar epithelial cells. Korean J Physiol Pharmacol (2017) 0.75
Stromal contributions to the carcinogenic process. Mol Carcinog (2016) 0.75
Analysis of different components in the peritumoral tissue microenvironment of colorectal cancer: A potential prospect in tumorigenesis. Mol Med Rep (2016) 0.75
Phospho-AXL is widely expressed in glioblastoma and associated with significant shorter overall survival. Oncotarget (2017) 0.75
Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread. Oncotarget (2017) 0.75
Inhibition of Lysyl Oxidases Impairs Migration and Angiogenic Properties of Tumor-Associated Pericytes. Stem Cells Int (2017) 0.75
Tumor angiogenesis: therapeutic implications. N Engl J Med (1971) 35.36
A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell (2008) 18.18
A perivascular niche for brain tumor stem cells. Cancer Cell (2007) 11.55
Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science (1997) 10.54
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest (2003) 8.34
Endothelial/pericyte interactions. Circ Res (2005) 8.24
Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development (1999) 7.12
Glioblastoma stem-like cells give rise to tumour endothelium. Nature (2010) 6.18
Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell (2011) 6.12
Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J Clin Invest (2006) 6.12
Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol (2000) 5.94
Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol (2007) 5.50
Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol (2001) 5.17
Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol (2008) 5.06
Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol (2002) 5.04
The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol (2005) 4.54
Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res (2003) 4.39
Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res (2010) 4.15
Real-time imaging reveals the single steps of brain metastasis formation. Nat Med (2009) 3.95
Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. FASEB J (2003) 3.62
Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev (2003) 3.48
The perivascular niche regulates breast tumour dormancy. Nat Cell Biol (2013) 3.36
Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell (2013) 3.32
Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest (2003) 3.31
Specialization of tumour vasculature. Nat Rev Cancer (2002) 3.30
Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell (2012) 3.19
All MSCs are pericytes? Cell Stem Cell (2008) 3.12
Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature (2008) 3.05
Central nervous system pericytes in health and disease. Nat Neurosci (2011) 2.90
Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol (2009) 2.74
Pericytes limit tumor cell metastasis. J Clin Invest (2006) 2.55
Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3. J Cell Biol (2006) 2.50
Chondrogenic and adipogenic potential of microvascular pericytes. Circulation (2004) 2.48
Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol (2003) 2.37
The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study. Lab Invest (1978) 2.32
The pericyte--a review. Tissue Cell (1986) 2.27
CNS microvascular pericytes exhibit multipotential stem cell activity. J Cereb Blood Flow Metab (2006) 2.16
Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am J Pathol (2003) 1.99
Early contribution of pericytes to angiogenic sprouting and tube formation. Angiogenesis (2003) 1.89
Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells (2014) 1.89
Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J (2001) 1.86
Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am J Hematol (2010) 1.84
Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102. Cancer Res (2007) 1.83
Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis. Arthritis Res Ther (2005) 1.81
Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. Cancer Res (2004) 1.72
Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am J Pathol (1991) 1.63
Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy. Am J Pathol (2003) 1.52
PDGFRβ signaling regulates mural cell plasticity and inhibits fat development. Dev Cell (2011) 1.45
The role of pericytes in angiogenesis. Int J Dev Biol (2011) 1.42
Pericyte function in the physiological central nervous system. Neurosci Res (2014) 1.40
Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse. Dev Biol (2010) 1.34
Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients. Oncology (2005) 1.32
Cellular mechanisms of CNS pericytes. Brain Res Bull (2000) 1.31
Angiogenesis and oncogenesis. J Natl Cancer Inst (1978) 1.30
The adult human brain harbors multipotent perivascular mesenchymal stem cells. PLoS One (2012) 1.30
Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo. Lab Invest (2002) 1.30
Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation. Cancer Res (2008) 1.24
Not all MSCs can act as pericytes: functional in vitro assays to distinguish pericytes from other mesenchymal stem cells in angiogenesis. Stem Cells Dev (2013) 1.21
The Growth of Malignant Disease in Man and the Lower Animals, with special reference to the Vascular System. Proc R Soc Med (1908) 1.14
CNS microvascular pericytes express macrophage-like function, cell surface integrin alpha M, and macrophage marker ED-2. Microvasc Res (1996) 1.10
Skeletal muscle pericyte subtypes differ in their differentiation potential. Stem Cell Res (2012) 1.09
Targeting the PD1/PD-L1 axis in melanoma: biological rationale, clinical challenges and opportunities. Crit Rev Oncol Hematol (2013) 1.03
Induced regeneration of calvaria by bone morphogenetic protein (BMP) in dogs. Clin Orthop Relat Res (1985) 1.02
Role of pericytes in skeletal muscle regeneration and fat accumulation. Stem Cells Dev (2013) 1.01
Contrasting effects of sunitinib within in vivo models of metastasis. Angiogenesis (2012) 1.00
Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma. Cancer (2012) 0.97
Brain capillary pericytes contribute to the immune defense in response to cytokines or LPS in vitro. Brain Res (2014) 0.94
Molecular definition of the pro-tumorigenic phenotype of glioma-activated microglia. Glia (2013) 0.93
Brain vascular pericytes following ischemia have multipotential stem cell activity to differentiate into neural and vascular lineage cells. Stem Cells (2015) 0.92
Type-1 pericytes participate in fibrous tissue deposition in aged skeletal muscle. Am J Physiol Cell Physiol (2013) 0.91
Investigation of pericytes, hypoxia, and vascularity in bladder tumors: association with clinical outcomes. Oncol Res (2008) 0.90
Pericyte-endothelial crosstalk: implications and opportunities for advanced cellular therapies. Transl Res (2014) 0.90
Recruitment and retention: factors that affect pericyte migration. Cell Mol Life Sci (2013) 0.90
Structural fragility of blood vessels and peritoneum in calponin h1-deficient mice, resulting in an increase in hematogenous metastasis and peritoneal dissemination of malignant tumor cells. Cancer Res (2001) 0.90
Pericyte dynamics during angiogenesis: new insights from new identities. J Vasc Res (2014) 0.89
Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma. J Neuroimmunol (2013) 0.89
Glioblastoma: a pathogenic crosstalk between tumor cells and pericytes. PLoS One (2014) 0.89
Brain pericytes acquire a microglial phenotype after stroke. Acta Neuropathol (2014) 0.87
Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts. Prostate Cancer Prostatic Dis (2008) 0.85
Brain mesenchymal stem cells: The other stem cells of the brain? World J Stem Cells (2014) 0.85
Targeting olfactomedin-like 3 inhibits tumor growth by impairing angiogenesis and pericyte coverage. Mol Cancer Ther (2012) 0.85
Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice. Oncotarget (2014) 0.84
Pericytes support neutrophil transmigration via interleukin-8 across a porcine co-culture model of the blood-brain barrier. Brain Res (2013) 0.82
Pericyte-coverage of human tumor vasculature and nanoparticle permeability. Biol Pharm Bull (2012) 0.81
Tumor-derived vascular pericytes anergize Th cells. J Immunol (2013) 0.81
Pericytes on the tumor vasculature: jekyll or hyde? Cancer Microenviron (2012) 0.80
Pericyte contractility controls endothelial cell cycle progression and sprouting: insights into angiogenic switch mechanics. Am J Physiol Cell Physiol (2014) 0.78
Inhibition of Lysyl Oxidases Impairs Migration and Angiogenic Properties of Tumor-Associated Pericytes. Stem Cells Int (2017) 0.75